Dentons and Latham & Watkins advised ATAI Life Sciences on the deal, while Davis Polk advised the underwriters. Clinical-stage biopharmaceutical company ATAI Life Sciences launched its…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
